Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Article metrics

Nat. Med. 24, 282–291 (2018); published online 12 February 2018; corrected after print 6 March 2018

In the version of this article initially published, Omid Shah's name was misspelled as Omid Sha. The error has been corrected in the PDF and HTML versions of this article.

Additional information

The online version of the original article can be found at https://doi.org/10.1038/nm.4484

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mathew, N., Baumgartner, F., Braun, L. et al. Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med 24, 526 (2018) doi:10.1038/nm0418-526c

Download citation

Further reading